Drugs / Buprenorphine/Naloxone
last change Sep 2001 re-read 3 minutes ago

Buprenorphine/Naloxone

Developed for
opiate dependence
Investigated by
National Institute on Drug Abuse (NIDA) · New York MDRU

Trials 1

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00015340 Aug 1999 → Aug 2001 opiate dependence National Institute on Drug Abuse (NIDA) Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Buprenorphine/Naloxone ClinicalTrials.gov intervention name — accepted as the source's own label NCT00015340 ↗